vs

Side-by-side financial comparison of Alignment Healthcare, Inc. (ALHC) and Gen Digital (GEN). Click either name above to swap in a different company.

Gen Digital is the larger business by last-quarter revenue ($1.2B vs $1.0B, roughly 1.2× Alignment Healthcare, Inc.). Gen Digital runs the higher net margin — 15.5% vs -1.1%, a 16.6% gap on every dollar of revenue. On growth, Alignment Healthcare, Inc. posted the faster year-over-year revenue change (44.4% vs 28.5%). Over the past eight quarters, Alignment Healthcare, Inc.'s revenue compounded faster (26.9% CAGR vs 13.2%).

Alignment Healthcare, Inc. is a U.S.-based healthcare provider offering Medicare Advantage plans for seniors. It adopts a value-based care model, partnering with local providers to deliver personalized coordinated medical services, prescription drug coverage and supplemental benefits to members across multiple U.S. states.

Gen Digital Inc. is a multinational software company co-headquartered in both Tempe, Arizona (USA) and Prague, Czech Republic (EU). The company provides cybersecurity software, financial technology, and services. Gen is a Fortune 500 company and a member of the S&P 500 stock-market index. It is listed at both NASDAQ and Prague Stock Exchange. Its portfolio includes Norton, Avast, LifeLock, Avira, AVG, ReputationDefender, MoneyLion and CCleaner.

ALHC vs GEN — Head-to-Head

Bigger by revenue
GEN
GEN
1.2× larger
GEN
$1.2B
$1.0B
ALHC
Growing faster (revenue YoY)
ALHC
ALHC
+15.9% gap
ALHC
44.4%
28.5%
GEN
Higher net margin
GEN
GEN
16.6% more per $
GEN
15.5%
-1.1%
ALHC
Faster 2-yr revenue CAGR
ALHC
ALHC
Annualised
ALHC
26.9%
13.2%
GEN

Income Statement — Q4 FY2025 vs Q3 FY2026

Metric
ALHC
ALHC
GEN
GEN
Revenue
$1.0B
$1.2B
Net Profit
$-11.0M
$192.0M
Gross Margin
78.4%
Operating Margin
-1.0%
34.9%
Net Margin
-1.1%
15.5%
Revenue YoY
44.4%
28.5%
Net Profit YoY
64.6%
6.1%
EPS (diluted)
$-0.04
$0.31

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ALHC
ALHC
GEN
GEN
Q1 26
$1.2B
Q4 25
$1.0B
$1.2B
Q3 25
$993.7M
$1.3B
Q2 25
$1.0B
Q1 25
$926.9M
$1.0B
Q4 24
$701.2M
$986.0M
Q3 24
$692.4M
$974.0M
Q2 24
$681.3M
$965.0M
Net Profit
ALHC
ALHC
GEN
GEN
Q1 26
$192.0M
Q4 25
$-11.0M
$134.0M
Q3 25
$3.7M
$135.0M
Q2 25
$15.7M
Q1 25
$-9.1M
$142.0M
Q4 24
$-31.1M
$159.0M
Q3 24
$-26.4M
$161.0M
Q2 24
$-24.0M
$181.0M
Gross Margin
ALHC
ALHC
GEN
GEN
Q1 26
78.4%
Q4 25
78.2%
Q3 25
78.8%
Q2 25
Q1 25
80.3%
Q4 24
80.4%
Q3 24
80.1%
Q2 24
80.3%
Operating Margin
ALHC
ALHC
GEN
GEN
Q1 26
34.9%
Q4 25
-1.0%
35.9%
Q3 25
0.8%
35.5%
Q2 25
2.2%
Q1 25
-0.6%
41.3%
Q4 24
-3.2%
37.9%
Q3 24
-2.8%
41.3%
Q2 24
-2.7%
43.2%
Net Margin
ALHC
ALHC
GEN
GEN
Q1 26
15.5%
Q4 25
-1.1%
11.0%
Q3 25
0.4%
10.7%
Q2 25
1.5%
Q1 25
-1.0%
14.1%
Q4 24
-4.4%
16.1%
Q3 24
-3.8%
16.5%
Q2 24
-3.5%
18.8%
EPS (diluted)
ALHC
ALHC
GEN
GEN
Q1 26
$0.31
Q4 25
$-0.04
$0.21
Q3 25
$0.02
$0.22
Q2 25
$0.07
Q1 25
$-0.05
$0.22
Q4 24
$-0.15
$0.26
Q3 24
$-0.14
$0.26
Q2 24
$-0.13
$0.29

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ALHC
ALHC
GEN
GEN
Cash + ST InvestmentsLiquidity on hand
$604.2M
Total DebtLower is stronger
$323.2M
$8.4B
Stockholders' EquityBook value
$179.3M
$2.3B
Total Assets
$1.1B
$15.8B
Debt / EquityLower = less leverage
1.80×
3.61×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ALHC
ALHC
GEN
GEN
Q1 26
Q4 25
$604.2M
Q3 25
$644.1M
Q2 25
$503.8M
Q1 25
$479.5M
$1.0B
Q4 24
$470.6M
$883.0M
Q3 24
$381.0M
$737.0M
Q2 24
$363.7M
$644.0M
Total Debt
ALHC
ALHC
GEN
GEN
Q1 26
$8.4B
Q4 25
$323.2M
$8.7B
Q3 25
$322.7M
$8.9B
Q2 25
$322.3M
Q1 25
$321.9M
$8.3B
Q4 24
$321.4M
$8.5B
Q3 24
$212.0M
$8.5B
Q2 24
$211.7M
$8.5B
Stockholders' Equity
ALHC
ALHC
GEN
GEN
Q1 26
$2.3B
Q4 25
$179.3M
$2.5B
Q3 25
$161.9M
$2.4B
Q2 25
$141.0M
Q1 25
$108.1M
$2.3B
Q4 24
$99.9M
$2.2B
Q3 24
$114.5M
$2.1B
Q2 24
$123.7M
$2.0B
Total Assets
ALHC
ALHC
GEN
GEN
Q1 26
$15.8B
Q4 25
$1.1B
$16.1B
Q3 25
$1.1B
$16.4B
Q2 25
$1.0B
Q1 25
$895.6M
$15.5B
Q4 24
$782.1M
$15.4B
Q3 24
$692.3M
$15.5B
Q2 24
$716.3M
$15.4B
Debt / Equity
ALHC
ALHC
GEN
GEN
Q1 26
3.61×
Q4 25
1.80×
3.54×
Q3 25
1.99×
3.75×
Q2 25
2.29×
Q1 25
2.98×
3.64×
Q4 24
3.22×
3.94×
Q3 24
1.85×
4.06×
Q2 24
1.71×
4.33×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ALHC
ALHC
GEN
GEN
Operating Cash FlowLast quarter
$-50.4M
Free Cash FlowOCF − Capex
$-55.4M
FCF MarginFCF / Revenue
-5.5%
Capex IntensityCapex / Revenue
0.5%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$113.1M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ALHC
ALHC
GEN
GEN
Q1 26
Q4 25
$-50.4M
$541.0M
Q3 25
$144.6M
$409.0M
Q2 25
$29.1M
Q1 25
$16.6M
$473.0M
Q4 24
$-8.7M
$326.0M
Q3 24
$26.2M
$158.0M
Q2 24
$23.5M
$264.0M
Free Cash Flow
ALHC
ALHC
GEN
GEN
Q1 26
Q4 25
$-55.4M
$535.0M
Q3 25
$139.1M
$405.0M
Q2 25
$21.1M
Q1 25
$8.4M
$470.0M
Q4 24
$-18.0M
$318.0M
Q3 24
$16.9M
$156.0M
Q2 24
$11.8M
$262.0M
FCF Margin
ALHC
ALHC
GEN
GEN
Q1 26
Q4 25
-5.5%
43.9%
Q3 25
14.0%
32.2%
Q2 25
2.1%
Q1 25
0.9%
46.5%
Q4 24
-2.6%
32.3%
Q3 24
2.4%
16.0%
Q2 24
1.7%
27.2%
Capex Intensity
ALHC
ALHC
GEN
GEN
Q1 26
Q4 25
0.5%
0.5%
Q3 25
0.6%
0.3%
Q2 25
0.8%
Q1 25
0.9%
0.3%
Q4 24
1.3%
0.8%
Q3 24
1.3%
0.2%
Q2 24
1.7%
0.2%
Cash Conversion
ALHC
ALHC
GEN
GEN
Q1 26
Q4 25
4.04×
Q3 25
38.77×
3.03×
Q2 25
1.86×
Q1 25
3.33×
Q4 24
2.05×
Q3 24
0.98×
Q2 24
1.46×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ALHC
ALHC

Segment breakdown not available.

GEN
GEN

Cyber Safety Platform$819.0M66%
Trust Based Solutions$421.0M34%
Net Interest Income On Notes Receivable$4.0M0%

Related Comparisons